This is not just another tool to image cancer. The probe is a two-for-one: detect cancer and distinguish one type from another. Together, they develop a cancer fingerprint.
Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology—a sugar-transporting biosensor—researchers at Michigan Technological University hope to reduce that timeframe down to minutes.
A collaborative team of chemists and engineers from Michigan Tech lays the groundwork for this vision in two new papers. In the Royal Society of Chemistry’s journal Chemical Communication (DOI: 10.1039/c7cc09809j), the team explains the basic science behind multicolor probes that enable targeting of a cancer-relevant fructose transporter, delving into the image-based detection of cancer cells. In the journal Biosensors (DOI: 10.3390/bios8020039), the team addresses applications for breast cancer detection and differentiating nonmalignant, pre-malignant and malignant cancer cells.
GLUT5 transports fructose and cancer loves sugar
Two Michigan Tech researchers collaborated on the studies. Marina Tanasova, assistant professor of chemistry, and Smitha Rao, assistant professor of biomedical engineering, turned a 10-minute office meeting into a two-year collaboration built on a tiny fluorescent probe that seeks out the fructose transporter named GLUT5.
Cells need carbohydrates; facilitative glucose transporters (GLUTs) bring nutrients in and out of cells. When metabolic swings kick in—say, from cancer development—the overall make-up of GLUTs change so that more or less GLUTs are active. Fructose transporters like GLUT5 are of particular interest because of the direct connection between fructose uptake and cancer development, which also changes as cancer progresses and becomes malignant.
In their Chemical Communications paper, Tanasova and Rao’s team report on the design and validation of the fluorescent probes, called ManCous, to observe GLUT5 activity in a cell. They document the multicolored fluorescence that distinguishes GLUT5-rich cells from those deficient in GLUT5. The follow up Biosensors paper provides a proof-of-principle use of these probes as tools to assess and compare GLUT5 and metabolic activity of different cell types, including normal cells and different cancer subtypes.
“We came closer to a basic screening of cells’ GLUT composition—one that both detects cancer and distinguishes type,” Tanasova says, adding that while the concept is elegant, developing the technology is not easy. “From basic science to application, there is a lot of transformation that has to happen.”
Engineering better cancer detection takes collaboration
By better understanding the science behind sugar transporters, the team is more equipped to build technology that captures an accurate and precise GLUT fingerprint of cancerous cells.
“This probe is like a Swiss army knife,” Rao says, explaining that cancer detection is not the only use for the probe. “The more we learn about cancer through these probes, the more opportunities we have to apply them—which means more chances to treat different cancers, hopefully cure them, and at least prevent their spread and maximize drug delivery.”
What makes the probe so versatile is its ability to not only seek out and highlight cancer cells, but also to reveal the metabolic nuances of different stages of cancer development. While cancer generally gobbles up fructose, the GLUT5 and metabolic activity of nonmalignant, pre-malignant and malignant breast cancer cells do vary, which is what Rao, Tanasova and their team explored in the Biosensors paper. They found that ManCou probes allow for parallel analysis and quantification of GLUT5 and metabolic activity of cells just after a 10-minute incubation period. The notable differences in fluorescence intensity observed between normal cells and cancer cells, as well as different cancer types, provide important points of differentiation between different cell types and make these probes promising tools for cancer detection and diagnostics.
The Latest on: Cancer fingerprint
via Google News
The Latest on: Cancer fingerprint
- 'Titan of Maryland,' Senate President Emeritus Mike Miller, has diedon January 15, 2021 at 6:20 pm
WE BEGIN WITH SOME SAD NEWS TO PASS ALONG TONIGHT FORMER MARYLAND SENATE PRESIDENT MIKE MILLER HAS DIED DEBORAH: THE FAMILY JUST RELEASED A STATEMENT SAYING HE DIED PEACEFULLY THIS AFTERNOON AT HIS ...
- An unusual mission in Afghanistan, and the troops who suffered to carry it outon January 15, 2021 at 10:00 am
Once fired at, U.S. troops could shoot back and kill the otherwise shadowy enemy. “Stir the pot. Shake it up. If necessary, take fire,” is the way an officer describes an average day in Afghanistan in ...
- Who killed JonBenet Ramsey? An investigator's dying wish keeps the search going with his familyon January 13, 2021 at 6:23 am
She is now tasked along with other members of Smit’s family with solving his last case as part of his dying wish -- that of 6-year-old JonBenét Ramsey. Watch the full story on "20/20" Friday at 9 p.m.
- mRNA vaccines could vanquish COVID-19 today, cancer tomorrowon January 13, 2021 at 12:00 am
It can tell our cells to make whatever protein we want. That includes the antigens of many other diseases besides COVID-19.
- QIMR Berghofer scientist awarded Metcalf Prize for stem cell researchon January 11, 2021 at 6:05 pm
QIMR Berghofer researcher, Associate Professor Steven Lane, has been awarded the Metcalf Prize for Stem Cell Research for his work into how ...
- mRNA Vaccines Could Vanquish Covid Today, Cancer Tomorrowon January 8, 2021 at 11:40 pm
And then, after battling cancer herself, she made the crucial ... You find the antigen, get its fingerprint, reverse-engineer the cellular instructions to target the culprit and let the body ...
- 7 DNA fingerprints that decide who may get cancer discoveredon January 4, 2021 at 3:18 am
Lifestyle, or put another way 'bad habits', is one of the textbook explanations for why some people are at higher risk for cancer.
via Bing News